This PhD project at the University of Leicester focuses on the genetic epidemiology of bronchiectasis, a chronic respiratory disease that has seen a significant rise in incidence and prevalence globally. Once considered rare, bronchiectasis is now recognised as the third most common chronic respiratory disease, highlighting the urgent need for advanced research into its genetic and epidemiological underpinnings.

Hosted within the Department of Population Health Sciences, this research opportunity will leverage cutting-edge approaches in bioinformatics, genetics, genomics, human genetics, medical statistics, and epidemiology. The project aims to unravel the genetic factors contributing to bronchiectasis, utilizing large-scale datasets and advanced statistical methods to identify genetic variants associated with disease susceptibility, progression, and outcomes.

Supervision will be provided by Dr K Coley and Prof L Wain, both of whom have extensive expertise in respiratory genetics and population health. The successful candidate will join a vibrant research environment with access to state-of-the-art facilities and collaborative opportunities within the university and with external partners.

Applicants should possess a strong academic background in a relevant discipline such as genetics, genomics, epidemiology, bioinformatics, or medical statistics. Experience or a keen interest in genetic epidemiology and computational analysis is highly desirable. Proficiency in English is required for non-native speakers, in line with university requirements.

While the funding status is not specified in this announcement, prospective students are encouraged to consult the University of Leicester's website or contact the department for information on potential funding opportunities. The application deadline is 19 January 2026, providing ample time for interested candidates to prepare their materials.

This project offers an excellent opportunity for motivated students to contribute to impactful research in respiratory genetics and public health, with the potential to inform clinical practice and improve patient outcomes.